
Nvidia reported stronger-than-expected Q2 results with adjusted EPS of $1.04 on revenue of $46.7 billion, and issued robust Q3 guidance of $54 billion, surpassing analyst estimates. Despite the overall beat, shares declined 1.4% premarket as data center revenue of $41.1 billion narrowly missed expectations, primarily due to U.S. restrictions on H20 chip sales to China. The company confirmed no H20 shipments to China in Q2 or the current quarter and excluded this revenue from Q3 guidance, highlighting persistent geopolitical uncertainty in the critical Chinese market, even as management maintains strong long-term confidence in AI demand and the Blackwell product line.
Nvidia reported a solid second quarter, surpassing analyst expectations with adjusted EPS of $1.04 and revenue of $46.7 billion, against forecasts of $1.01 and $46.1 billion respectively. Despite this outperformance and a robust Q3 revenue forecast of $54 billion that also beat estimates, the company's shares declined 1.4% in premarket trading. The negative market reaction stems from the critical Data Center segment, which, despite growing 56% to $41.1 billion, fell just short of the $41.34 billion consensus. This miss is directly attributed to U.S. restrictions on H20 chip sales to China, with Nvidia confirming zero H20 shipments in Q2. The strong Q3 guidance notably excludes any potential H20 revenue, which management estimates could add between $2 billion and $5 billion if geopolitical issues subside, highlighting both a significant risk and a potential upside catalyst. While analysts at Jefferies remain highly bullish, citing 'rock solid' demand with Hopper and Blackwell platforms 'sold out', others like Wolfe Research noted the guidance was a 'touch low' relative to elevated street expectations, underscoring the high bar set for the company's performance amidst ongoing geopolitical and macroeconomic uncertainties surrounding the AI sector.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mildly positive
Sentiment Score
0.40
Ticker Sentiment